NFE2L2 and acute kidney injury: Moreover, recent studies have found that STC1, a conserved glycoprotein with anti-apoptosis and function, could target Nrf2 to reduce kidney injury and provide a promising preventive target for the treatment of CI-AKI (Zhao et al., 2020).